Head-to-head · WeighScore
Ageless vs RedBox Rx
The verdict
RedBox Rx takes it — 70.2/100 to 69.7/100, but only just.
RedBox Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing. Ageless is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Ageless | RedBox Rx |
|---|---|---|
| WeighScore | 69.7/100 | 70.2/100 |
| Grade | C | C |
| Scorecard rank | #89 | #122 |
| Semaglutide | $279/mo month-to-month (the advertised "from" figures are 3-, 6- and 12-month prepays) | $269/mo (all doses, 6-month plan, compounded) |
| Tirzepatide | $349/mo month-to-month (the advertised "from" figures are 3-, 6- and 12-month prepays) | $429/mo |
| Coverage | Varies by state | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #89 · C
FDAWarning letter issued to Lovely Meds, Inc. dba Lovely Meds in September 2025. Try Ageless's own medical-oversight page identifies Lovely Meds, Inc. as the company that operates tryageless.com. The letter concerns lovelymeds.com, does not name tryageless.com, and FDA has not closed it out. See the FDA warning-letter database.
Strengths
- Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
- Every GLP-1 format has a real month-to-month rung as well as prepay tiers, so nobody is forced into a commitment in order to buy at all
- Sublingual tirzepatide drops are genuinely cheaper than the injection without a commitment — $199/mo month-to-month against $349 for the shot
- The SLIM50 code is stated as a recurring $50 discount rather than a first-month teaser that expires
- Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
Where it loses points
- The advertised entry prices are twelve-month rungs, not monthly rates: the hero's "from $159/mo" and the "FROM $199 / $249" cards are annual plans charged as one payment of $1,908, $2,388 or $2,988 — buying by the month costs $279 for semaglutide and $349 for tirzepatide
- The same company sells the same semaglutide injection at two prices — a storefront catalog at $119–$229 for a month's supply as a one-time purchase, and the plan page our link resolves to at $279/mo — with no page reconciling them, and the storefront's checkout is disabled so its figures are never actually charged
- The storefront disagrees with itself as well: for the same item its struck-through "was" anchor is $169 in one place and $229 in another
- Sermorelin is priced four different ways across the company's own pages ($189, $126, $239–$289, $199–$299), so a figure read off one of them is not the figure the funnel charges
- The default variant on a product page is the LOWEST dose, so any "from" price is the bottom of a dose ladder that runs up to $199–$299
- TRT has no month-to-month rung at all — the shortest purchasable term is a three-month prepay, from $387 charged up front
- Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
- Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
- No published state-availability list, so coverage is only settled inside the funnel
Graded #122 · C
Strengths
- Flat, dose-independent pricing on both semaglutide and tirzepatide
- Offers both weekly injections and daily oral tablets
- Includes unlimited provider follow-ups, a metabolic panel and a dietitian session
- Backed by grocery-pharmacy parent company Hy-Vee
Where it loses points
- Does not serve every state (for example Mississippi is excluded)
- Does not publicly name its compounding pharmacy
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.